The Full-Year Continuing Appropriations and Extensions Act of 2025 provides $650M in funding for the CDMRP. Congress provided further guidance for CDMRP program-level funding, including funding for the Prostate Cancer Research Program. The FY25 PCRP intends to support innovative, high-impact prostate cancer research.
The Full-Year Continuing Appropriations and Extensions Act of 2025 provides $650M in funding for the CDMRP.
A team led by researchers at Baylor College of Medicine has identified flavonoids, natural compounds found in plants, that are toxic to bladder cancer cells cultured in the lab.
City of Hope researchers at AACR.City of Hope presented more than 74 sessions at this year’s American Association for Cancer Research Annual Meeting in Chicago, highlighting breakthroughs in diagnostics, treatment options and AI-powered precision medicine.
Before two consecutive congressional hearings on the Trump administration’s “skinny budget” proposal on May 14, Sen. Bernie Sanders (I-VT), ranking member of the Senate Health, Education, Labor, and Pensions Committee, released a report assessing the administration’s impact on biomedical research.
The Association of American Cancer Institutes started a monthly newsletter roundup titled “Defending Cancer Research Digest.”
Researchers at the University of Chicago Medicine Comprehensive Cancer Center have discovered that high doses of radiation cause growth in existing metastatic tumors that weren’t directly treated with radiation.
How is the enterprise of cancer research doing after the first 100 days of the Trump administration?
The Ministry of Health of the Republic of Indonesia and the CRUK Scotland Institute entered into a partnership to advance cancer research, build capacity in cancer care, and support evidence-based health policies.
University of Oklahoma researchers have discovered one reason why the brain tumor glioblastoma is so aggressive.
